JSLLPharmaceuticals
Jeena Sikho Lifecare Limited — Profit & Loss Statement
₹539.70
-6.87%
Jeena Sikho Lifecare Limited Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | 0.00 | -0.61 Cr | 0.21 Cr | — |
| Tax Rate For Calcs | 0.26 | 0.26 | 0.24 | 0.26 | — |
| Normalized EBITDA | 131.28 Cr | 99.43 Cr | 50.71 Cr | 18.72 Cr | — |
| Total Unusual Items | 0.00 | 0.00 | -2.51 Cr | 0.80 Cr | — |
| Total Unusual Items Excluding Goodwill | 0.00 | 0.00 | -2.51 Cr | 0.80 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 90.73 Cr | 69.21 Cr | 33.74 Cr | 11.23 Cr | — |
| Reconciled Depreciation | 8.71 Cr | 5.10 Cr | 3.13 Cr | 3.31 Cr | — |
| Reconciled Cost Of Revenue | 31.26 Cr | 21.56 Cr | 21.77 Cr | 16.47 Cr | — |
| EBITDA | 131.28 Cr | 99.43 Cr | 48.20 Cr | 19.51 Cr | — |
| EBIT | 122.57 Cr | 94.33 Cr | 45.08 Cr | 16.20 Cr | — |
| Net Interest Income | -0.51 Cr | -0.41 Cr | 0.66 Cr | -0.96 Cr | — |
| Interest Expense | 0.51 Cr | 0.41 Cr | 0.55 Cr | 1.11 Cr | — |
| Normalized Income | 90.73 Cr | 69.21 Cr | 35.64 Cr | 10.64 Cr | — |
| Net Income From Continuing And Discontinued Operation | 90.73 Cr | 69.21 Cr | 33.74 Cr | 11.23 Cr | — |
| Total Expenses | 352.91 Cr | 236.52 Cr | 157.65 Cr | 131.77 Cr | — |
| Diluted Average Shares | 12.43 Cr | 12.43 Cr | 12.32 Cr | 12.43 Cr | — |
| Basic Average Shares | 12.43 Cr | 12.43 Cr | 12.32 Cr | 12.43 Cr | — |
| Diluted EPS | 7.30 | 5.57 | 2.74 | 0.90 | — |
| Basic EPS | 7.30 | 5.57 | 2.74 | 0.90 | — |
| Diluted NI Availto Com Stockholders | 90.73 Cr | 69.21 Cr | 33.74 Cr | 11.23 Cr | — |
| Net Income Common Stockholders | 90.73 Cr | 69.21 Cr | 33.74 Cr | 11.23 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 90.73 Cr | 69.21 Cr | 33.74 Cr | 11.23 Cr | — |
| Net Income Including Noncontrolling Interests | 90.73 Cr | 69.21 Cr | 33.74 Cr | 11.19 Cr | — |
| Net Income Continuous Operations | 90.73 Cr | 69.21 Cr | 33.74 Cr | 11.19 Cr | — |
| Tax Provision | 31.34 Cr | 24.71 Cr | 10.79 Cr | 3.90 Cr | — |
| Pretax Income | 122.07 Cr | 93.92 Cr | 44.53 Cr | 15.09 Cr | — |
| Other Non Operating Income Expenses | 6.41 Cr | 6.44 Cr | 0.14 Cr | 0.47 Cr | — |
| Special Income Charges | 0.00 | 0.00 | -2.51 Cr | 0.80 Cr | — |
| Net Non Operating Interest Income Expense | -0.51 Cr | -0.41 Cr | 0.66 Cr | -0.96 Cr | — |
| Interest Expense Non Operating | 0.51 Cr | 0.41 Cr | 0.55 Cr | 1.11 Cr | — |
| Operating Income | 116.16 Cr | 87.89 Cr | 46.24 Cr | 14.79 Cr | — |
| Operating Expense | 321.65 Cr | 214.96 Cr | 135.89 Cr | 115.29 Cr | — |
| Other Operating Expenses | 212.45 Cr | 143.95 Cr | 42.94 Cr | 31.68 Cr | — |
| Depreciation And Amortization In Income Statement | 8.71 Cr | 5.10 Cr | 3.13 Cr | 3.31 Cr | — |
| Depreciation Income Statement | 8.71 Cr | 5.10 Cr | 3.05 Cr | 3.20 Cr | — |
| Gross Profit | 437.81 Cr | 302.84 Cr | 182.13 Cr | 130.08 Cr | — |
| Cost Of Revenue | 31.26 Cr | 21.56 Cr | 21.77 Cr | 16.47 Cr | — |
| Total Revenue | 469.07 Cr | 324.41 Cr | 203.90 Cr | 146.55 Cr | — |
| Operating Revenue | 469.07 Cr | 324.41 Cr | 203.90 Cr | 146.55 Cr | — |
| Interest Income | — | 3.14 Cr | 1.60 Cr | 0.22 Cr | 0.14 Cr |
| Rent Expense Supplemental | — | 17.44 Cr | 5.85 Cr | 1.80 Cr | 1.36 Cr |
| Other Special Charges | — | -1.15 Cr | -0.54 Cr | -0.80 Cr | 0.13 Cr |
| Write Off | — | 0.00 | 3.05 Cr | 0.00 | 0.01 Cr |
| Total Other Finance Cost | — | 0.36 Cr | 0.40 Cr | 0.07 Cr | 0.07 Cr |
| Interest Income Non Operating | — | 3.14 Cr | 1.60 Cr | 0.22 Cr | 0.14 Cr |
| Amortization | — | 0.04 Cr | 0.08 Cr | 0.11 Cr | 0.08 Cr |
| Selling General And Administration | — | 56.69 Cr | 40.53 Cr | 44.71 Cr | 41.36 Cr |
| Selling And Marketing Expense | — | 43.33 Cr | 30.09 Cr | 35.11 Cr | 33.35 Cr |
| General And Administrative Expense | — | 13.36 Cr | 10.44 Cr | 9.60 Cr | 8.01 Cr |
| Rent And Landing Fees | — | 17.44 Cr | 5.85 Cr | 1.80 Cr | 1.36 Cr |
| Minority Interests | — | — | 0.26 Cr | 0.04 Cr | — |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Jeena Sikho Lifecare Limited
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.